Synergistic Anticancer Effects of Polyphyllin I and Evodiamine on Freshly-Removed Human Gastric Tumors

Thymidylate synthase mRNA levels in plasma and tumor as potential predictive biomarkers for raltitrexed sensitivity in gastric cancer

(2012) Jie Shen et al.   INTERNATIONAL JOURNAL OF CANCER

Evodiamine, a dual catalytic inhibitor of type I and II topoisomerases, exhibits enhanced inhibition against camptothecin resistant cells

(2012) Xiaobei Pan et al.   PHYTOMEDICINE

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

mRNA Expression of BRCA1, PIAS1, and PIAS4 and Survival After Second-line Docetaxel in Advanced Gastric Cancer

(2011) Jia Wei et al.   JNCI-Journal of the National Cancer Institute

Effects of polyphyllin I on growth inhibition of human non-small lung cancer cells and in xenograft

(2010) M. Kong et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method

(2010) T.-C. Chou   CANCER RESEARCH

Aprataxin Tumor Levels Predict Response of Colorectal Cancer Patients to Irinotecan-based Treatment

(2010) H. Dopeso et al.   CLINICAL CANCER RESEARCH

The Prognostic Value of BRCA1 mRNA Expression Levels Following Neoadjuvant Chemotherapy in Breast Cancer

(2010) Mireia Margeli et al.   PLoS One

Evodiamine Stabilizes Topoisomerase I-DNA Cleavable Complex to Inhibit Topoisomerase I Activity

(2009) Agnes Chan et al.   MOLECULES

ERCC1 mRNA levels and survival of advanced gastric cancer patients treated with a modified FOLFOX regimen

(2008) J Wei et al.   BRITISH JOURNAL OF CANCER

Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer

(2008) David Cunningham et al.   NEW ENGLAND JOURNAL OF MEDICINE

Polyphyllin D induces mitochondrial fragmentation and acts directly on the mitochondria to induce apoptosis in drug-resistant HepG2 cells

(2007) Rose C.Y. Ong et al.   CANCER LETTERS